Latest filing published 23 Oct 2017 for Syros Pharmaceuticals, Inc., €1,422.
Filing timeline
BuySaleInsider track record
No signal scores available.
Colleen Elizabeth DeSimone: trading record in brief
All filings by Colleen Elizabeth DeSimone on record concern Syros Pharmaceuticals, Inc. We count 2 filings, every one of them for a trade on 23 October 2017.
Every open-market trade on record is a sale: 1 sale worth €7,512. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 23 October 2017: an option exercise of €1,422, in Syros Pharmaceuticals, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Colleen Elizabeth DeSimone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 550 shares@ US$3.04Common StockSEC:0001179110-17-013416:0
- 550 shares@ US$16.06Common StockSEC:0001179110-17-013416:1
2 of 2 declarations
